Rhonda Henry Named President of Emmes BioPharma Group
News provided by
Share this article
Share this article
ROCKVILLE, Md., April 19, 2021 /PRNewswire/ Emmes, a global, full-service Clinical Research Organization (CRO) dedicated to supporting the advancement of public health and biopharmaceutical innovation, today announced that Rhonda Henry has joined the company as President of Emmes BioPharma. Naming a leader of our biopharma group is a major, positive step in our strategy to expand and diversify our business, said Dr. Christine Dingivan, Chief Executive Officer of Emmes.
Rhonda Henry
Henry joins Emmes with 30 years of clinical research experience, most recently as vice president of patient solutions at PPD. One of the largest clinical research companies in the world, PPD has about 24,000 employees working in 46 countries. She began her career there as a clinical research associate in 1991 and gained increasing responsibilities in a number of management position
Rhonda Henry Named President of Emmes BioPharma Group
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Internet of Things (IoT) in Healthcare Market May Set New Growth Story | GE Healthcare, Koninklijke Philips, SAP, Medtronic
sandiegosun.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sandiegosun.com Daily Mail and Mail on Sunday newspapers.